SNPs around the exon region of the GLP1R gene were genotyped in a small sample of people with poorly controlled type 2 diabetes, who received exenatide for 3 days (5 μg twice daily) and were also treated with a continuous subcutaneous insulin infusion [35]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.